Navigation Links
CRH Medical Corporation announces substantial increase in patient visits
Date:2/5/2008

VANCOUVER, Feb. 5 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today for the year ended December 31, 2007, it had 13,461 patient visits at its Centers for Colorectal Health compared to 1,699 patient visits for the same period in 2006.

Commenting on this achievement, Edward Wright, CEO of CRH Medical Corporation stated, "In 2007, we demonstrated the strong demand for the CRH O'Regan hemorrhoid banding technology and treatment protocol. In 2008, we plan to open several additional Centers in new markets throughout the United States allowing CRH to further capitalize on this large and underserved market. According to the National Institutes of Health the prevalence rate of symptomatic hemorrhoids in the United States is approximately 4.4% of the population or 13.3 million people."

Centers open one year or longer continue to show strong growth, with patient visits increasing 485% for the three months ended December 31, 2007 compared to the same period in 2006.

Commenting on the CRH O'Regan Hemorrhoid Banding technology and treatment protocol, Dr. Iain Cleator, Chief Medical Director of CRH said, "The most important aspect of our technology and treatment protocol is that we are experiencing the same excellent results in each of our Centers. This means that our training methodology and treatment protocol is transferable and reproducible."

Dr. Carolyn Million, Medical Director of CRH's San Francisco Center, added, "As a Fellow of the American Society of Colon and Rectal Surgeons I have treated hemorrhoids for 15 years. In my opinion the CRH O'Regan banding technology and treatment protocol consistently provide a significantly higher level of patient satisfaction compared with other hemorrhoid treatments options."

About CRH Medical Corporation:

CRH Medical Corporation is utilizing the first single use, patented, disposable, hemorrhoid banding system through its Center for Colorectal Health facilities. According to the National Institute of Health approximately 50% of the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening its Center for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening and plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market. The Company's goal is to become the preeminent resource on colorectal health for consumers and medical professionals in North America.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy

or accuracy of this release.

CONTACT: Dean Linden, Investor Relations, CRH Medical Corporation at (604) 633-1440, or ir@crhmedcorp.com; Additional information may also be found by visiting the Company's website at http://www.crhmedcorp.com, or the SEDAR website at http://www.sedar.com


'/>"/>
SOURCE CRH Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Phase II Medical Manufacturing Selects IQMS for ERP Solution
2. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
3. Presidents Proposed 2009 Medicare Budget Would Weaken Seniors Access to Durable Medical Equipment and Therapies Required in the Home
4. 7th Annual Wiley Prize in Biomedical Sciences Awarded to Dr. Richard P. Lifton
5. ATS Medical Expects Fourth Quarter Revenue to Increase by Approximately 32%
6. MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records
7. MCM Completes LAC+USC Replacement Medical Facility Project
8. MCM Completes Westwood Replacement Hospital - Ronald Reagan UCLA Medical Center
9. Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation
10. Globus Medical Announces Record Revenue for 2007
11. MedStar Health Unveils Rx for Success Program at Vivien T. Thomas Medical Arts Academy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes with 44 ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a very high-dynamic ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... January 20, 2017 , ... D R Burton Healthcare ... device, was featured in a study indicating superior performance against competitive products in ... of Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was published in ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: ... by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene Gaapf, ... and poetry collections. , “I have been writing since high school and have ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details What can be ... going to grow at the fastest rates? This visiongain ... trends, opportunities and prospects. Our 190-page report provides ... areas in the industry and the future market prospects. ... the all the major categories of the ophthalmic devices ...
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor ... market is expected to grow at a CAGR of 27.1% ... 38.7% in the second half of the forecast period. The market ... to 2027. The market is estimated at $1,058 million in 2016, ... ...
Breaking Medicine Technology: